Mike Terretti's Daily Pharma News

Mike Terretti's Daily Pharma News By Mike Terretti 919-781-0400x112

Mike Terretti’s focus is the Pharmaceutical and Biotechnology Industries in Executive Recruitment. THe following information drives all the growth and opportunity in our market.

Web

Images

News

Mike Terretti's Daily Pharma News >> PHARMACEUTICAL INDUSTRY

January 08, 2009

members login here

Focus Channels

  Pharmaceutical Industry
  Biotech
  Genetics
  Healthcare related
  Biological sciences
  Human sciences

Participate

Build a News Circle

Receive News Briefings

Add this Circle to favorites

Share this News Circle

Subscribe to this News Circle

Useful Links

Pharmaceutical Job Openings for Mike Terretti

Senior Director of Technology Search and Development -Oncology

My client is a well funded Public Biotech Corp in the Bay area
They are developing innovative small molecule oncology treatments.
Senior Director of Technology Search and Development
Responsibilities:
- Evaluate in-licensing of new technologies (drug compounds) with technology-market evaluation
- Patent estate and IP portfolio management
- Possible international travel (Asia and Europe), but <20% of time
- Ability... Read More Add Comment

>>	PHARMACEUTICAL INDUSTRY

InteKrin Therapeutics to Present at the 27th Annual JP Morgan Healthcare Conference

Houston Chronicle - 76 Minutes ago

LOS ALTOS, Calif., Jan. 8 /PRNewswire/ -- InteKrin Therapeutics, Inc., will present at the 27th Annual JP Morgan Global Healthcare Conference at 9:00 a.m. Pacific Time on Tuesday, January 13, 2009, to

Arena Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference Montana's News Station

Dendreon Announces Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference Montana's News Station

all 13 news articles >> Add Comment

BRIEF-American Medical gets FDA OK for prolapse systemÂ 16 mins ago

CNBC - 4 Hours ago

Jan 8 (Reuters) - American Medical Systems Holdings Inc: * Announces FDA clearance for elevate anterior and apical prolapse repair system * Says limited launch in the first half of 2009 with a full commercial

BRIEF-American Medical gets FDA OK for prolapse system CNBC

American Medical Systems Announces FDA Clearance for Elevate(R) Anterior and Apical Forbes.com

all 7 news articles >> Add Comment

Chemed Corporation to Present at the 27th Annual JPMorgan Healthcare Conference

Forbes.com - 59 Minutes ago

Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 27th Annual JPMorgan Healthcare Conference on Tuesday, January 13, 2009, at approximately 4:30 p.m. PST at the

ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference BioSpace

Ikaria Inc. to Present at 27th Annual JPMorgan Healthcare Conference BioSpace

all 5 news articles >> Add Comment

Collegium Pharmaceutical Announces FDA Approval of AllerNaze(TM), a Nasal Inhaled

Forbes.com - 4 Hours ago

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved AllerNaze(TM) (triamcinolone acetonide, USP) Nasal Spray,

Collegium Pharmaceutical Announces FDA Approval of AllerNaze™, a Nasal Inhaled Earthtimes.org

Collegium Pharmaceutical Announces FDA Approval of AllerNaze„, a Nasal Inhaled Business Wire

all 6 news articles >> Add Comment

AcelRx Pharmaceuticals Hires Roman Skowronski, M.D., Ph.D. as Vice President of

Globe Investor - 4 Hours ago

REDWOOD CITY, Calif., Jan. 8 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. announced today it has hired Dr. Roman Skowronski as Vice President, Clinical Development. In this new position, Dr. Skowronski

AcelRx Pharmaceuticals Hires Roman Skowronski, M.D., Ph.D. as PR Newswire via MSN Money

all 1 news articles >> Add Comment

UPDATE 1-Glaxo CEO sees more bolt-on acquisitions in 2009Â 33 mins ago

CNBC - 88 Minutes ago

By Ransdell Pierson and Ben Hirschler NEW YORK/LONDON, Jan 8 (Reuters) - GlaxoSmithKline expects to make further acquisitions in 2009 to bolster its business in emerging markets and in selling over-the-counter

UPDATE 1-Glaxo CEO sees more bolt-on acquisitions in 2009 Reuters India

Glaxo CEO sees more bolt-on acquisitions in 2009 Yahoo! UK and Ireland

all 2 news articles >> Add Comment

Javelin Pharmaceuticals CEO Martin J. Driscoll to Present at J.P. Morgan's 27th

Forbes.com - 2 Hours ago

Javelin Pharmaceuticals (NYSE Alternext US: JAV) announced today that Martin J. Driscoll, CEO will present at J.P. Morgan's 27th Annual Healthcare Conference at 11:30 a.m. PT on Thursday, January 15,

Javelin Pharmaceuticals CEO Martin J. Driscoll to Present at J.P. Morgan's Street Insider

all 1 news articles >> Add Comment

Celator(R) Pharmaceuticals To Present at Biotech Showcase 2009

MarketWatch - 4 Hours ago

/PRNewswire via COMTEX/ -- Celator Pharmaceuticals today announced that Scott Jackson, chief executive officer, is scheduled to present at the Biotech Showcase 2009 in San Francisco. Mr. Jackson will

Celator Pharmaceuticals To Present at Biotech Showcase 2009 Pharma Live

all 1 news articles >> Add Comment

Pharmaceutical Industry Works to Polish Image

Washington Post - 4 Hours ago

Industry Works to Polish Its Image - @import @import @import @import @import @import @import @import @import

Add Comment

Cramer's New Top Five Dow Stock

CNBC - 5 Hours ago

Sectors:Pharmaceuticals | Health Care Companies:Johnson and Johnson Johnson & Johnson is the play, Cramer said Wednesday, for anyone looking to buy a strong defensive stock. And with market enthusiasm

Cramer's Top Five Dow Stocks: Johnson & Johnson CNBC

Cramer's Top Five Dow Stocks CNBC

all 3 news articles >> Add Comment

Levi & Korsinsky, LLP Investigates Breach of Fiduciary Duty by the Board of thinkorswim

MarketWatch - 4 Hours ago

(GlobeNewswire via COMTEX) -- Levi & Korsinsky, LLP is investigating breaches of fiduciary duty and other violations of state law by the board of directors of thinkorswim Group Inc. ('thinkorswim' or

Levi & Korsinsky, LLP Investigates Breach of Fiduciary Duty by the Board of Street Insider

Levi & Korsinsky, LLP Investigates Breach of Fiduciary Duty by the Board of Indevus Yahoo! Canada

all 3 news articles >> Add Comment

UPDATE 1-Teva says major acquisition unlikely soon

CNBC - 3 Hours ago

NEW YORK, Jan 8 (Reuters) - Teva Pharmaceutical Industries Ltd is unlikely to make a big acquisition in the near future, but might consider a piece of a company, the generic drugmaker's top U.S. executive

Teva says major acquisition unlikely soon Forbes.com

all 1 news articles >> Add Comment

Michael Schmertzler Joins Kolltan Pharmaceuticals as CEO and Director

Forbes.com - 4 Hours ago

Kolltan Pharmaceuticals, a next-generation oncology therapeutics company, announced today the appointment of Michael Schmertzler as Chief Executive Officer and Director, and Yaron Hadari, Ph. D., as Vice

Add Comment

Wyeth to Present at the JP Morgan Healthcare Conference

MarketWatch - 2 Hours ago

/PRNewswire-FirstCall via COMTEX/ -- Wyeth (: Last: Delayed quote data Analyst Create alert Insider Discuss Financials , , ) announced today that it will present at the JP Morgan Healthcare Conference

Add Comment

BRIEF-Glaxo CEO says vaccine business very compelling

Forbes.com - 4 Hours ago

Jan 8 (Reuters) - GlaxoSmithKline PLC: * CEO Andrew Witty says vaccine business very compelling * Glaxo CEO says vaccine business has advantage of 'massive barriers to entry' * Glaxo CEO says cost of

Add Comment

www.ONN.tv Reports: Johnson & Johnson Big Strangle Seller on January 08, 2009

Forbes.com - 4 Hours ago

Recorded live from the heart of the options universe in downtown Chicago, The Sidewinder Report is www. ONN.tv's daily look at unusual options activity. Today, www. ONN.tv Chief Investment Strategist

Add Comment

Kolltan Pharmaceuticals Raises over $35 Million in Series A Financing

Forbes.com - 4 Hours ago

Kolltan Pharmaceuticals, Inc. announced today that the Company has raised over $35 million in its Series A preferred stock financing. Kolltan is a next-generation oncology therapeutics company applying

Synosia Therapeutics Raises CHF32 Million in Series B Private Financing BioSpace

all 1 news articles >> Add Comment

Satyam goes off Sensex, replaced by Sun Pharma

The Hindu - 94 Minutes ago

Mumbai (PTI): The Bombay Stock Exchange on Thursday said it will replace Satyam Computer with Sun Pharmaceutical in its benchmark index Sensex with effect from January 12. Satyam would also be removed

BSE de-lists Satyam, Sun Pharma replaces scrip on Sensex NewKerala.com

all 1 news articles >> Add Comment

BRIEF-Teva exec says big deal unlikely anytime soon

Forbes.com - 5 Hours ago

Jan 8 (Reuters) - Teva Pharmaceutical Industries Ltd: * Exec says not likely company will make a big acquisition 'any time soon' * Exec says company focusing on barr integration ((New York Equities Desk;

Add Comment

Drug may help prevent side-effects of chemo: study

CBC - 3 Hours ago

A new drug may help prevent the nausea and vomiting that patients receiving chemotherapy often experience, a Japanese trial suggests. In the February issue of Lancet Oncology, Dr. Mitsue Saito of the

A new drug may help prevent the nausea and vomiting that patients receiving chemotherapy Sympatico

DOR Drug for Radiation Side Effect Gets Fast-Track Status FDA News

all 2 news articles >> Add Comment

Hugh Johnson Of Johnson Illington Advisors Explains Why He's "A Little More Hopeful"

RTTNews.com - 6 Hours ago

US Economic News European Economic News Asian Economic News All Economic News FX Top Stories Currency Alerts Mkt Sensitive News Politics European Mkt Updates Asian Mkt Updates Treasury Mkt Updates Daily

Hugh Johnson Of Johnson Illington Advisors Calls Jobless Claims Data A "Good Sign" Nasdaq

all 1 news articles >> Add Comment

Pomerantz Law Firm Investigating Claims On Behalf of Investors in Satyam Computer

MarketWatch - 3 Hours ago

(GlobeNewswire via COMTEX) -- The recently disclosed fraud by Satyam Computer Services Ltd., which serves as a back office for one third of the Fortune 500 companies and is one of India's largest outsourcing

The Shuman Law Firm Investigates Indevus Pharmaceutical, Inc. NewsBlaze

The Shuman Law Firm Investigates American Land Lease, Inc. Yahoo! Canada

all 2 news articles >> Add Comment

S&P Picks and Pans: Wal-Mart, Satyam, Intuitive Surgical, Wyeth, Citigroup

BusinessWeek - 4 Hours ago

From Excluding fuel, December comp-store sales grew 1.7%, below our 2.6% estimate. Sam's Club growth of 0.1% was significantly below our 3.5% forecast, as small-business demand declined. Core U.S. business

S&P Picks and Pans: Wal-Mart, Satyam, Intuitive Surgical, Wyeth, Citigroup BusinessWeek

all 1 news articles >> Add Comment

Anadys Pharmaceuticals Hits Highest Level In Over A Year On Increased Volume

RTTNews.com - 4 Hours ago

Anadys Pharmaceuticals Inc. (ANDS: News ) is extending its gains on increased volume and has reached its highest level in about a year and a half, trading at $3.80 up $1.89 from Wednesday's close. by

US jobless to hit highest level in 60 years The Times

all 1 news articles >> Add Comment

IBC Life Sciences, Pudong Science & Technology Commission, ZhangJiang Group and

MarketWatch - 3 Hours ago

(MARKET WIRE via COMTEX) -- IBC Life Sciences, the worldwide leader in scientific, technological and business conferences and courses for the life science industry, has entered into a collaborative partnership

IBC Life Sciences: IBC Life Sciences, Pudong Science & Technology Commission, ZhangJiang Market Wire

IBC Life Sciences, Pudong Science & Technology Commission, ZhangJiang Group Street Insider

all 2 news articles >> Add Comment



	Already a member? Sign in


	Email Address:
	Password:


Forget your password?

Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms of Use | Privacy Policy | Need Help? | Site Map